Rhesus monkeys are native to South, Central, and Southeast Asia. They can be found in a variety of habitats including forests, grasslands, and urban areas. **

Rhesus monkeys typically live for around 25 years in the wild, but they can live up to 40 years in captivity. Their lifespan can vary depending on factors such as habitat, diet, and access to healthcare. These monkeys are known for their adaptability and resilience, which contributes to their longevity in various environments. **

Rhesus monkeys are not typically sold to the general public as they are considered a protected species in many countries. They are often only available through licensed breeders or research facilities for scientific purposes. It is important to note that owning a Rhesus monkey as a pet may be illegal in some areas and requires special permits due to their protected status. It is recommended to research local laws and regulations before attempting to purchase a Rhesus monkey. **

Yes, it is normal for the doctor to charge for the Rhesus-negative test, as it is a specific and necessary test for pregnant women. The test is important to determine if the mother is Rhesus-negative and if there is a potential risk of Rhesus incompatibility with the baby. It is standard procedure to conduct this test, regardless of the Rhesus status of the husband, as it is crucial for the health and well-being of the mother and the baby. **

It is possible for parents with positive Rhesus factor to have a child with a negative Rhesus factor if both parents are heterozygous for the Rhesus factor. This means that both parents carry one positive and one negative Rhesus factor allele. When they have a child, there is a chance that the child inherits the negative Rhesus factor allele from both parents, resulting in a negative Rhesus factor. This is a result of genetic inheritance and the random combination of alleles during reproduction. **

Rhesus antibodies, also known as D-antibodies, are injected after birth to prevent a condition known as hemolytic disease of the newborn (HDN). This condition occurs when a mother with Rh-negative blood type is exposed to Rh-positive blood from her baby during pregnancy or childbirth, leading to the mother's immune system producing antibodies against the baby's red blood cells. By injecting Rhesus antibodies after birth, any Rh-positive red blood cells from the baby that may have entered the mother's bloodstream are destroyed before her immune system can mount a significant response, preventing HDN from occurring in subsequent pregnancies. **

Rhesus antibodies, also known as D antibodies, are injected after birth to prevent a condition called hemolytic disease of the newborn (HDN). This condition occurs when a mother with Rh-negative blood type is exposed to Rh-positive blood from her baby during pregnancy or childbirth. The mother's immune system can develop antibodies against the Rh-positive blood, which can then attack the baby's red blood cells in future pregnancies. By injecting Rhesus antibodies after birth, any Rh-positive blood from the baby that may have entered the mother's bloodstream is targeted and destroyed before her immune system can develop its own antibodies, thus preventing HDN in future pregnancies. **

A Punnett square for the Rhesus factor is a tool used to predict the possible genotypes and phenotypes of offspring based on the Rhesus factor (Rh) alleles inherited from their parents. The Rhesus factor is a protein found on the surface of red blood cells, and individuals can be either Rh positive (Rh+) or Rh negative (Rh-). The Punnett square helps to show the different combinations of Rh alleles that offspring can inherit from their parents, and the likelihood of each possible outcome. This can be useful in understanding the inheritance patterns of the Rhesus factor and predicting the likelihood of a child having a certain blood type. **